A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report - Image 1

£95.92

National Academies Press A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report

Name: A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report
Brand: National Academies Press
Price: 60.49 GBP
Availability: InStock

Public Health

Price History & Forecast

Last 86 days • 86 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 86 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £60 (50 days, 58.1%)

Price range: £59 - £96

Price levels: 3 different prices over 86 days

Description

Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of worlda (TM)s hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the second of two, builds off the conclusions of the first report and outlines a strategy for hepatitis reduction over time and specific actions to achieve them.

Product Specifications

Brand: National Academies Press
Format: paperback
ASIN: 0309457297
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues > Public Health
Domain: Amazon UK
Release Date: 30 June 2017
Listed Since: 01 April 2017

Barcode

No barcode data available

National Academies Press A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Viral Hepatitis Molecular Biology Diagnosis and Control (Volume 10) (Perspectives in Medical Virology, Volume 10)

Hepatitis C: Methods and Protocols: 510 (Methods in Molecular Biology, 510)

Current Management of Hepatitis C Virus, An Issue of Clinics in Liver Disease (Volume 19-4) (The Clinics: Internal Medicine, Volume 19-4)

Hepatitis C: State of the Art at the Millennium: A Bound Compilation of Issues 1 and 2 of Seminars in Liver Disease (2000)

Hepatitis E Virus: 1417 (Advances in Experimental Medicine and Biology, 1417)

Die immunsuppressive Therapie der chronisch-aktiven Hepatitis

Prevention of Progression in Chronic Liver Disease: An Update on SNMC (Stronger Neo-Minophagen C). In honour of Hans Popper's 100th birthday: 138A (Falk Symposium, 138A)

Diseases of the Liver and Bile Ducts: A Practical Guide to Diagnosis and Treatment (Current Clinical Practice)

Silymarin protection role in modulating ribavirin genotoxicity: Evaluation of the antioxidant silymarin role in modulating the in vivo genotoxicity of the antiviral drug ribavirin

Hepatocellular Carcinoma: Diagnosis and Treatment (Current Clinical Oncology)

Multidisciplinary Treatment of Hepatocellular Carcinoma: 190 (Recent Results in Cancer Research, 190)

Liver Pathology, An Issue of Gastroenterology Clinics of North America (Volume 46-2) (The Clinics: Internal Medicine, Volume 46-2)

HIV and Liver Disease

Liver Cancer

Elimination of Viral Hepatitis B and C - Global Initiatives, National Programs, and Scientific Advances

Handbook of Research on Herbal Liver Protection: Hepatoprotective Plants

Hepatocyte Transplantation: 126 (Falk Symposium, 126)

Liver Regeneration and Carcinogenesis: Molecular and Cellular Mechanisms

Cirrhosis: A Practical Guide to Management

Gene Therapy for HIV and Chronic Infections: 848 (Advances in Experimental Medicine and Biology, 848)

Sinusoidal Cells in Liver Diseases: Role in their Pathophysiology, Diagnosis, and Treatment

Human Polyomaviruses: Molecular and Clinical Perspectives

Autoimmune Liver Disease: 96b (Falk Symposium, 96b)

The Impact of Obesity and Nutrition on Chronic Liver Diseases, An Issue of Clinics in Liver Disease (Volume 18-1) (The Clinics: Internal Medicine, Volume 18-1)